Literature DB >> 22882857

FHL2 inhibits the Id3-promoted proliferation and invasive growth of human MCF-7 breast cancer cells.

Yi-Hong Chen1, Zhi-Qiang Wu, Ya-Li Zhao, Yi-Ling Si, Ming-Zhou Guo, Wei-Dong Han.   

Abstract

BACKGROUND: Id3 plays a key role in the progression of breast cancer. Previously, four and a half LIM protein (FHL2) was identified as a repressor of Id family proteins by interacting with them. This study aimed to investigate the effects of FHL2 on the transcriptional regulation and oncogenic activities of Id3 in human breast cancer cells.
METHODS: Cell transfection was performed with SuperFect reagent. Stable transfectants that overexpressed Id3 were obtained by selection on G418. The level of Id3 protein was determined by Western blotting analysis. Dual luciferase assays were used to measure the effect of Id3 and FHL2 on E47-mediated transcriptional activity in MCF-7 human breast cancer cells. The MTT assay was used to measure cell proliferation. The transwell assay was used to measure the invasive capacity of MCF-7 cancer cells.
RESULTS: Id3 markedly repressed transcription mediated by the basic helix-loop-helix (bHLH) factor E47 in MCF-7 cells. This Id3-mediated repression was effectively antagonized by FHL2. Overexpression of Id3 markedly promoted the proliferation and invasive capacity of MCF-7 cells; however, these effects were significantly suppressed by the overexpression of FHL2.
CONCLUSIONS: FHL2 can inhibit the proliferation and invasive growth of human breast cancer cells by repressing the functional activity of Id3. The functional roles of FHL2-Id3 signaling in the development of human breast cancer need further research.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22882857

Source DB:  PubMed          Journal:  Chin Med J (Engl)        ISSN: 0366-6999            Impact factor:   2.628


  7 in total

1.  Four and a half LIM domains 2 contributes to the development of human tongue squamous cell carcinoma.

Authors:  Qiang Wang; Xiaoying Wang; Xiufen Tian; Ronghua Tang; Xin Xu
Journal:  J Mol Histol       Date:  2016-01-12       Impact factor: 2.611

2.  High level of FHL2 exacerbates the outcome of non-small cell lung cancer (NSCLC) patients and the malignant phenotype in NSCLC cells.

Authors:  Na Li; Ling Xu; Ji Zhang; Yongyu Liu
Journal:  Int J Exp Pathol       Date:  2022-04-02       Impact factor: 2.793

3.  Intratumoral estrogen concentration and expression of estrogen-induced genes in male breast carcinoma: comparison with female breast carcinoma.

Authors:  Kiyoshi Takagi; Takuya Moriya; Masafumi Kurosumi; Kimako Oka; Yasuhiro Miki; Akiko Ebata; Takashi Toshima; Shoji Tsunekawa; Hiroyuki Takei; Hisashi Hirakawa; Takanori Ishida; Shin-Ichi Hayashi; Junichi Kurebayashi; Hironobu Sasano; Takashi Suzuki
Journal:  Horm Cancer       Date:  2012-10-18       Impact factor: 3.869

Review 4.  The FHL2 regulation in the transcriptional circuitry of human cancers.

Authors:  Cyanne Ye Cao; Simon Wing-Fai Mok; Vincent Wing-Sang Cheng; Stephen Kwok-Wing Tsui
Journal:  Gene       Date:  2015-07-26       Impact factor: 3.688

5.  c-Abl kinase regulates cell proliferation and ionizing radiation-induced G2/M arrest via phosphorylation of FHL2.

Authors:  Guang-Fei Wang; Xiayang Niu; Hainan Liu; Qincai Dong; Yebao Yao; Di Wang; Xuan Liu; Cheng Cao
Journal:  FEBS Open Bio       Date:  2021-05-19       Impact factor: 2.693

6.  The four and a half LIM domains 2 (FHL2) regulates ovarian granulosa cell tumor progression via controlling AKT1 transcription.

Authors:  G Hua; C He; X Lv; L Fan; C Wang; S W Remmenga; K J Rodabaugh; L Yang; S M Lele; P Yang; A R Karpf; J S Davis; C Wang
Journal:  Cell Death Dis       Date:  2016-07-14       Impact factor: 8.469

7.  Pathway landscapes and epigenetic regulation in breast cancer and melanoma cell lines.

Authors:  Mariama El Baroudi; Dario La Sala; Caterina Cinti; Enrico Capobianco
Journal:  Theor Biol Med Model       Date:  2014-05-07       Impact factor: 2.432

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.